Genome-wide CRISPR screening shows mTOR inhibition causes ferroptosis in head and neck cancer, indicating potential therapeutic targets.
Ferrostatin-1 attenuated the effects of mTORi and auranofin in vitro. (Related to Figure 6)
No takes yet. Share an insight, caveat, or question.
Koshizuka et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: